The GLOW Stack: Why GHK-Cu, BPC-157 and TB-500 Work Together for Repair and Regeneration
At Australian Peptides, the GLOW Stack brings together three of the most researched repair and regeneration peptides available: GHK-Cu (copper tripeptide-1), BPC-157 (Body Protection Compound 157), and TB-500 (Thymosin Beta-4 fragment). Each compound has its own distinct mechanism and published research base — but when you look at what each one does, the logic of combining them becomes clear.
This post breaks down each component, explains the research behind it, and explains why the combination covers the full spectrum of tissue repair and skin regeneration from three complementary angles.
GHK-Cu: The Regeneration Signal
GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. Its plasma concentration declines significantly with age — from around 200 ng/mL in young adults to approximately 80 ng/mL by the age of 60 — a decline that mirrors many of the tissue changes associated with ageing.
The research on GHK-Cu spans over four decades and covers a remarkable breadth of biological activity. Its most thoroughly documented effects include stimulation of collagen and elastin synthesis in dermal fibroblasts, promotion of wound healing and tissue remodelling, antioxidant and anti-inflammatory activity, activation of skin-repairing genes, and support for hair follicle health.
In the context of the GLOW Stack, GHK-Cu plays the role of the regenerative signal: it activates the cellular machinery responsible for producing new structural tissue — collagen, elastin, glycosaminoglycans — and creates the biological environment in which repair can occur. Multiple randomised controlled trials in humans have validated its effects in topical dermatological applications, and as of April 2026 it is the fastest-growing peptide search term in Australia with over 1,000% year-on-year growth.
BPC-157: The Healing Accelerator
BPC-157 is a synthetic pentadecapeptide — 15 amino acids — derived from a protein sequence found in human gastric juice. With over 200 PubMed-indexed publications as of April 2026, it has one of the largest preclinical research bases of any peptide compound in this category.
BPC-157’s primary research applications centre on tissue repair and healing acceleration. In animal models, it has consistently demonstrated accelerated healing of tendons, ligaments, muscle fibres, and skin wounds. The mechanisms proposed include modulation of nitric oxide signalling, promotion of angiogenesis (growth of new blood vessels to injured tissue), upregulation of growth factor expression at wound sites, and direct cytoprotective effects on cells under stress.
In the context of the GLOW Stack, BPC-157 serves as the healing accelerator: it actively drives the repair process at sites of tissue damage, supporting the resolution of inflammation and the restoration of tissue architecture. Its gastrointestinal protective properties add an additional dimension — a healthy gut mucosal lining supports systemic nutrient absorption and reduces systemic inflammatory load, both relevant to skin and tissue health.
TB-500: The Mobility and Structural Rebuilder
TB-500 is a synthetic analogue of Thymosin Beta-4, a protein present in virtually every cell in the human body. Its central biological role involves regulating actin — one of the most abundant proteins in cells, critical to cell structure, movement, and division.
In research settings, TB-500 has been studied for its ability to promote cell migration to sites of injury, support the formation of new blood vessels, reduce local inflammation, and accelerate the healing of muscle, tendon, and connective tissue. It is often noted for effects on flexibility and range of motion alongside tissue healing — a combination that reflects its role in both structural rebuilding and the remodelling of extracellular matrix.
In the context of the GLOW Stack, TB-500 addresses the structural and mobility dimension of repair: supporting the physical rebuilding of tissue architecture, promoting cell movement into damaged areas, and facilitating the extracellular matrix remodelling that gives healed tissue its functional integrity.
Why the Combination Makes Sense
Looking at the three compounds together, a coherent picture emerges of three peptides that address tissue repair and regeneration from distinct but complementary mechanistic angles.
GHK-Cu activates the regenerative signal — stimulating the production of the structural proteins and extracellular components that healthy tissue is made from. BPC-157 drives the healing process — promoting angiogenesis, resolving inflammation, and accelerating the restoration of tissue at the cellular level. TB-500 rebuilds structure and mobility — supporting cell migration, extracellular matrix remodelling, and the physical architecture of repaired tissue.
Each compound operates through different primary pathways, which means the combination addresses repair biology more comprehensively than any single compound could achieve alone. For researchers designing protocols focused on tissue regeneration, wound healing, or skin biology, the GLOW Stack provides a research-grade combination that covers the breadth of known repair mechanisms.
Sourcing the GLOW Stack in Australia
All three components of the GLOW Stack are independently tested by Australian Peptides with batch-specific HPLC and mass spectrometry certificates. Products are sourced from GMP-accredited international laboratories and dispatched same-day from our Australian warehouse with cold-chain packaging to protect compound integrity in transit.